vs
Side-by-side financial comparison of SBC Medical Group Holdings Inc (SBC) and Sila Realty Trust, Inc. (SILA). Click either name above to swap in a different company.
Sila Realty Trust, Inc. is the larger business by last-quarter revenue ($50.1M vs $39.6M, roughly 1.3× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs 10.0%, a 25.9% gap on every dollar of revenue. On growth, Sila Realty Trust, Inc. posted the faster year-over-year revenue change (7.6% vs -10.9%). Over the past eight quarters, Sila Realty Trust, Inc.'s revenue compounded faster (-0.6% CAGR vs -15.0%).
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
Sila Realty Trust, Inc. is a U.S.-based real estate investment trust that owns, operates, and acquires high-quality income-generating commercial properties. Its core portfolio covers industrial logistics facilities, office assets and mixed-use properties, serving tenants across logistics, corporate and retail segments to deliver stable long-term returns.
SBC vs SILA — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $39.6M | $50.1M |
| Net Profit | $14.2M | $5.0M |
| Gross Margin | 73.1% | 88.9% |
| Operating Margin | 32.5% | — |
| Net Margin | 35.9% | 10.0% |
| Revenue YoY | -10.9% | 7.6% |
| Net Profit YoY | 117.2% | -54.9% |
| EPS (diluted) | $0.15 | $0.10 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $39.6M | $50.1M | ||
| Q3 25 | $43.4M | $49.8M | ||
| Q2 25 | $43.4M | $48.7M | ||
| Q1 25 | $47.3M | $48.3M | ||
| Q4 24 | $44.4M | $46.5M | ||
| Q3 24 | $53.1M | $46.1M | ||
| Q2 24 | $53.1M | $43.6M | ||
| Q1 24 | $54.8M | $50.6M |
| Q4 25 | $14.2M | $5.0M | ||
| Q3 25 | $12.8M | $11.6M | ||
| Q2 25 | $2.5M | $8.6M | ||
| Q1 25 | $21.5M | $7.9M | ||
| Q4 24 | $6.5M | $11.1M | ||
| Q3 24 | $2.8M | $11.9M | ||
| Q2 24 | $18.5M | $4.6M | ||
| Q1 24 | $18.8M | $15.0M |
| Q4 25 | 73.1% | 88.9% | ||
| Q3 25 | 70.6% | 88.1% | ||
| Q2 25 | 69.2% | 87.7% | ||
| Q1 25 | 79.7% | 86.9% | ||
| Q4 24 | 76.3% | 87.3% | ||
| Q3 24 | 81.5% | 87.4% | ||
| Q2 24 | 74.2% | 86.6% | ||
| Q1 24 | 72.1% | 89.0% |
| Q4 25 | 32.5% | — | ||
| Q3 25 | 36.6% | — | ||
| Q2 25 | 33.6% | — | ||
| Q1 25 | 51.1% | — | ||
| Q4 24 | 10.6% | — | ||
| Q3 24 | 26.1% | — | ||
| Q2 24 | 51.4% | — | ||
| Q1 24 | 44.6% | — |
| Q4 25 | 35.9% | 10.0% | ||
| Q3 25 | 29.6% | 23.3% | ||
| Q2 25 | 5.7% | 17.6% | ||
| Q1 25 | 45.4% | 16.4% | ||
| Q4 24 | 14.7% | 23.9% | ||
| Q3 24 | 5.3% | 25.9% | ||
| Q2 24 | 34.8% | 10.6% | ||
| Q1 24 | 34.2% | 29.6% |
| Q4 25 | $0.15 | $0.10 | ||
| Q3 25 | $0.12 | $0.21 | ||
| Q2 25 | $0.02 | $0.15 | ||
| Q1 25 | $0.21 | $0.14 | ||
| Q4 24 | $0.05 | $0.20 | ||
| Q3 24 | $0.03 | $0.21 | ||
| Q2 24 | $0.20 | $0.08 | ||
| Q1 24 | $0.20 | $0.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $164.1M | $32.3M |
| Total DebtLower is stronger | $42.8M | — |
| Stockholders' EquityBook value | $248.3M | $1.3B |
| Total Assets | $380.4M | $2.1B |
| Debt / EquityLower = less leverage | 0.17× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $164.1M | $32.3M | ||
| Q3 25 | $127.4M | $27.7M | ||
| Q2 25 | $152.7M | $24.8M | ||
| Q1 25 | $132.1M | $30.5M | ||
| Q4 24 | $125.0M | $39.8M | ||
| Q3 24 | $137.4M | $28.6M | ||
| Q2 24 | — | $87.0M | ||
| Q1 24 | — | $90.2M |
| Q4 25 | $42.8M | — | ||
| Q3 25 | $21.1M | — | ||
| Q2 25 | $7.1M | — | ||
| Q1 25 | $6.9M | — | ||
| Q4 24 | $6.6M | — | ||
| Q3 24 | $823.2K | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $248.3M | $1.3B | ||
| Q3 25 | $248.0M | $1.3B | ||
| Q2 25 | $244.6M | $1.4B | ||
| Q1 25 | $226.4M | $1.4B | ||
| Q4 24 | $195.1M | $1.4B | ||
| Q3 24 | $205.0M | $1.4B | ||
| Q2 24 | $8.8M | $1.5B | ||
| Q1 24 | $9.0M | $1.5B |
| Q4 25 | $380.4M | $2.1B | ||
| Q3 25 | $321.4M | $2.1B | ||
| Q2 25 | $315.3M | $2.0B | ||
| Q1 25 | $284.6M | $2.0B | ||
| Q4 24 | $266.1M | $2.0B | ||
| Q3 24 | $296.5M | $2.0B | ||
| Q2 24 | $19.5M | $2.1B | ||
| Q1 24 | $19.8M | $2.1B |
| Q4 25 | 0.17× | — | ||
| Q3 25 | 0.09× | — | ||
| Q2 25 | 0.03× | — | ||
| Q1 25 | 0.03× | — | ||
| Q4 24 | 0.03× | — | ||
| Q3 24 | 0.00× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $52.0M | $119.1M |
| Free Cash FlowOCF − Capex | $51.2M | — |
| FCF MarginFCF / Revenue | 129.3% | — |
| Capex IntensityCapex / Revenue | 2.0% | — |
| Cash ConversionOCF / Net Profit | 3.66× | 23.76× |
| TTM Free Cash FlowTrailing 4 quarters | $23.3M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $52.0M | $119.1M | ||
| Q3 25 | $-20.9M | $30.0M | ||
| Q2 25 | $-8.3M | $31.9M | ||
| Q1 25 | $1.9M | $24.1M | ||
| Q4 24 | $-7.3M | $132.8M | ||
| Q3 24 | $5.0M | $29.1M | ||
| Q2 24 | $19.2M | $31.6M | ||
| Q1 24 | $3.7M | $36.6M |
| Q4 25 | $51.2M | — | ||
| Q3 25 | $-20.9M | — | ||
| Q2 25 | $-8.6M | — | ||
| Q1 25 | $1.7M | — | ||
| Q4 24 | $-7.9M | — | ||
| Q3 24 | $4.6M | — | ||
| Q2 24 | $18.3M | — | ||
| Q1 24 | $3.0M | — |
| Q4 25 | 129.3% | — | ||
| Q3 25 | -48.3% | — | ||
| Q2 25 | -19.9% | — | ||
| Q1 25 | 3.5% | — | ||
| Q4 24 | -17.8% | — | ||
| Q3 24 | 8.7% | — | ||
| Q2 24 | 34.5% | — | ||
| Q1 24 | 5.4% | — |
| Q4 25 | 2.0% | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | 0.7% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 1.3% | — | ||
| Q3 24 | 0.8% | — | ||
| Q2 24 | 1.6% | — | ||
| Q1 24 | 1.3% | — |
| Q4 25 | 3.66× | 23.76× | ||
| Q3 25 | -1.63× | 2.59× | ||
| Q2 25 | -3.39× | 3.71× | ||
| Q1 25 | 0.09× | 3.06× | ||
| Q4 24 | -1.12× | 11.95× | ||
| Q3 24 | 1.77× | 2.43× | ||
| Q2 24 | 1.04× | 6.84× | ||
| Q1 24 | 0.20× | 2.44× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
SILA
Segment breakdown not available.
